| Q40176190 | A Case Report of Parvovirus B19 Infection in a Renal Allograft |
| Q34251955 | Association of human bocavirus 1 infection with respiratory disease in childhood follow-up study, Finland |
| Q34624583 | Bioportfolio: lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue |
| Q36058219 | Characterization of Markers of the Progression of Human Parvovirus B19 Infection in Virus DNA-Positive Plasma Samples |
| Q36589833 | Chronic Lyme Disease and Co-infections: Differential Diagnosis |
| Q36589340 | Clinical aspects of parvovirus B19 infection |
| Q41701831 | Clinical features of 10 fetuses with prenatally diagnosed parvovirus b19 infection and fetal hydrops. |
| Q35947888 | Complete remission of human parvovirus b19 associated symptoms by loxoprofen in patients with atopic predispositions |
| Q36793876 | Cynomolgus monkeys (Macaca fascicularis) experimentally infected with B19V and hepatitis A virus: no evidence of the co-infection as a cause of acute liver failure. |
| Q59315593 | Cytokine responses in acute and persistent human parvovirus B19 infection |
| Q38058285 | Emerging viral diseases in kidney transplant recipients |
| Q42192353 | Evaluation of the diagnostic work-up in children with myocarditis and idiopathic dilated cardiomyopathy. |
| Q55043498 | Human bocavirus and acute wheezing in children. |
| Q90102527 | Human bocavirus infection in Belgian children with respiratory tract disease |
| Q36538808 | Human bocavirus: passenger or pathogen in acute respiratory tract infections? |
| Q51868263 | Human parvovirus B19 in pediatric and adult recipients of allogeneic hematopoietic stem cell transplantation. |
| Q51874195 | Human parvoviruses B19, PARV4 and bocavirus in pediatric patients with allogeneic hematopoietic SCT. |
| Q40321614 | Infection and immunity for human parvovirus B19 in patients with febrile exanthema |
| Q90788873 | Interpretation of pathogen load in relationship to infectivity and pathogen reduction efficacy |
| Q99712526 | Molecular screening of the human parvoviruses B19 and bocavirus 1 in the study of congenital diseases as applied to symptomatic pregnant women and children |
| Q36234516 | No Definite Association between Human Parvovirus B19 Infection and Behçet Disease |
| Q40010116 | No evidence of persistent parvovirus B19 viremia among Iranian patients with HIV after a 1-year follow-up. |
| Q28484049 | No evidence of presence of parvovirus 4 in a Swedish cohort of severely immunocompromised children and adults |
| Q58666387 | Parvovirus B19 Achievements and Challenges |
| Q47147160 | Parvovirus B19 in the Context of Hematopoietic Stem Cell Transplantation: Evaluating Cell Donors and Recipients |
| Q24594590 | Parvovirus B19 infection in human pregnancy |
| Q40083769 | Parvovirus B19 integration into human CD36+ erythroid progenitor cells |
| Q34180261 | Persistence of human parvovirus B19 in multipotent mesenchymal stromal cells expressing the erythrocyte P antigen: implications for transplantation |
| Q80275713 | Recurrent anemia in kidney transplant recipients with parvovirus B19 infection |
| Q40369358 | Respiratory viruses, a common microbiological finding in neutropenic children with fever |
| Q34676329 | The determinants for the enzyme activity of human parvovirus B19 phospholipase A2 (PLA2) and its influence on cultured cells |
| Q40566146 | Virome characterisation from Guthrie cards in children who later developed acute lymphoblastic leukaemia |